Teladoc Health (NYSE:TDOC) shares are up on Thursday following the company’s latest earnings report, which highlighted a mix of revenue changes across its segments.
The stock is moving higher as the broader market is experiencing a mixed day, with the Nasdaq down 1.57% and the S&P 500 down 0.87%, indicating that the positive movement in Teladoc may be driven by company-specific factors rather than overall market trends.
Performance Highlights
Teladoc Health reported a quarterly loss of 14 cents per share, compared to the consensus loss of 18 cents.
Sales jumped slightly to $642.27 million, beating the consensus of $635.24 million.
Access fees revenue decreased by 4% to $521.6 million, while other revenue saw a significant increase of 24% to $120.7 million.
In the U.S., revenue fell 3% to $517.3 million, while international revenue rose 19% to $125.0 million. The Integrated Care segment reported a revenue increase of 5% to $409.1 million, while the BetterHelp segment experienced a 7% decline in revenue to $233.2 million.
Adjusted EBITDA increased 12% to $83.8 million.
Management Commentary
“We closed 2025 with …